ANXA2 and neoplasm: Conversely, LS301 is a cancer-accumulating agent that has been utilized for fluorescence imaging of a variety of tumor types14–16 and targets phosphorylated annexin A2 (pANXA2),17 which is overexpressed in many cancers.18